AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Dardevet, D.
Right arrow Articles by Moore, M. C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dardevet, D.
Right arrow Articles by Moore, M. C.
Agricola
Right arrow Articles by Dardevet, D.
Right arrow Articles by Moore, M. C.
American Journal of Clinical Nutrition, Vol. 88, No. 4, 986-996, October 2008
© 2008 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Portal infusion of amino acids is more efficient than peripheral infusion in stimulating liver protein synthesis at the same hepatic amino acid load in dogs1,2,3

Dominique Dardevet, Scot R Kimball, Leonard S Jefferson, Alan D Cherrington, Didier Rémond, Catherine A DiCostanzo and Mary Courtney Moore

1 From the Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN (DD, ADC, CAD, and MCM); INRA, Unité de Nutrition Humaine, UMR1019, Saint Genès Champanelle, France (DD and DR); and the Department of Cellular and Molecular Physiology, Penn State University College of Medicine, Hershey, PA (SRK and LSJ)

Background: Hepatic glucose uptake is enhanced by the portal delivery of glucose, which creates a negative arterioportal substrate gradient. Hepatic amino acid (AA) utilization may be regulated by the same phenomenon, but this has not been proven.

Objective: We aimed to assess hepatic AA balance and protein synthesis with or without a negative arterioportal AA gradient.

Design: Somatostatin was infused intravenously, and insulin and glucagon were replaced intraportally at 4- and 3-fold basal rates, respectively, in 3 groups (n = 9 each) of conscious dogs with catheters for hepatic balance measurement. Arterial glucose concentrations were clamped at 9 mmol/L. An AA mixture was infused intravenously to maintain basal concentrations (EuAA), intraportally to mimic the postmeal AA increase (PoAA), or intravenously (PeAA) to match the hepatic AA load in PoAA. Protein synthesis was assessed with a primed, continuous [14C]leucine infusion.

Results: Net hepatic glucose uptake in the PoAA condition was ≤50% of that in the EuAA and PeAA conditions (P < 0.05). In the PoAA and PeAA conditions, hepatic intracellular leucine concentrations were 2- to 2.5-fold those in the EuAA condition (P < 0.05); net hepatic leucine uptake and [14C]leucine utilization were {approx}2-fold greater (P < 0.05) and albumin synthesis was 30% greater (P < 0.05) in the PoAA condition than in the EuAA and PeAA conditions. Phosphorylation of ribosomal protein S6 [downstream of the mammalian target of Rapamycin complex 1 (mTORC1)] was significantly higher in the PoAA, but not PeAA, condition than in the EuAA condition.

Conclusions: Portal, but not peripheral, AA delivery significantly enhanced hepatic protein synthesis under conditions in which AAs, glucose, insulin, and glucagon did not differ at the liver, an effect apparently mediated by mTORC1 signaling.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The American Society for Nutrition